Beside the well-studied role of TRAIL in oncologic settings, an increasing amount of data has indicated the important biological activities of the TRAIL/TRAIL receptor systems also in diabetes mellitus [52–54]. This evidence concerns the gene TNFSF10 and diabetes mellitus.